REPORT ID 427

United States Veterinary Pharmaceuticals Market Report 2017

Publish Date
01-Dec-17
Pages
105
Format
Electronic (PDF)

In this report, the United States Veterinary Pharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Veterinary Pharmaceuticals in these regions, from 2012 to 2022 (forecast).

United States Veterinary Pharmaceuticals market competition by top manufacturers/players, with Veterinary Pharmaceuticals sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Zoetis(Pfizer)
    MERIAL
    Merial
    Lilly
    Bayer
    Boehringer
    Novartis
    Virbac
    Ceva
    Vetoquinol
    CAHIC
    Ringpu
    Dahuanong
    TECON
    BIOK
    Lukang Pharma
    JINYU Group
    China Animal Healthcare
    Jiangxi Yiling
    JIZHONG Pharmaceutical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Veterinary Biological Drugs
    Veterinary Preparations
    Others?
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Poultry
    Pets
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Veterinary Pharmaceuticals Market Report 2017
1 Veterinary Pharmaceuticals Overview
    1.1 Product Overview and Scope of Veterinary Pharmaceuticals
    1.2 Classification of Veterinary Pharmaceuticals by Product Category
        1.2.1 United States Veterinary Pharmaceuticals Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Veterinary Pharmaceuticals Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Veterinary Biological Drugs
        1.2.4 Veterinary Preparations
        1.2.5 Others?
    1.3 United States Veterinary Pharmaceuticals Market by Application/End Users
        1.3.1 United States Veterinary Pharmaceuticals Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Poultry
        1.3.3 Pets
        1.3.4 Other
    1.4 United States Veterinary Pharmaceuticals Market by Region
        1.4.1 United States Veterinary Pharmaceuticals Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Veterinary Pharmaceuticals Status and Prospect (2012-2022)
        1.4.3 Southwest Veterinary Pharmaceuticals Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Veterinary Pharmaceuticals Status and Prospect (2012-2022)
        1.4.5 New England Veterinary Pharmaceuticals Status and Prospect (2012-2022)
        1.4.6 The South Veterinary Pharmaceuticals Status and Prospect (2012-2022)
        1.4.7 The Midwest Veterinary Pharmaceuticals Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Veterinary Pharmaceuticals (2012-2022)
        1.5.1 United States Veterinary Pharmaceuticals Sales and Growth Rate (2012-2022)
        1.5.2 United States Veterinary Pharmaceuticals Revenue and Growth Rate (2012-2022)

2 United States Veterinary Pharmaceuticals Market Competition by Players/Suppliers
    2.1 United States Veterinary Pharmaceuticals Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Veterinary Pharmaceuticals Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Veterinary Pharmaceuticals Average Price by Players/Suppliers (2012-2017)
    2.4 United States Veterinary Pharmaceuticals Market Competitive Situation and Trends
        2.4.1 United States Veterinary Pharmaceuticals Market Concentration Rate
        2.4.2 United States Veterinary Pharmaceuticals Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Veterinary Pharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type

3 United States Veterinary Pharmaceuticals Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Veterinary Pharmaceuticals Sales and Market Share by Region (2012-2017)
    3.2 United States Veterinary Pharmaceuticals Revenue and Market Share by Region (2012-2017)
    3.3 United States Veterinary Pharmaceuticals Price by Region (2012-2017)

4 United States Veterinary Pharmaceuticals Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Veterinary Pharmaceuticals Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Veterinary Pharmaceuticals Revenue and Market Share by Type (2012-2017)
    4.3 United States Veterinary Pharmaceuticals Price by Type (2012-2017)
    4.4 United States Veterinary Pharmaceuticals Sales Growth Rate by Type (2012-2017)

5 United States Veterinary Pharmaceuticals Sales (Volume) by Application (2012-2017)
    5.1 United States Veterinary Pharmaceuticals Sales and Market Share by Application (2012-2017)
    5.2 United States Veterinary Pharmaceuticals Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Veterinary Pharmaceuticals Players/Suppliers Profiles and Sales Data
    6.1 Zoetis(Pfizer)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Zoetis(Pfizer) Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 MERIAL
        6.2.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 MERIAL Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Merial
        6.3.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Merial Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Lilly
        6.4.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Lilly Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Bayer
        6.5.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Bayer Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Boehringer
        6.6.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Boehringer Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Novartis
        6.7.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Novartis Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Virbac
        6.8.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Virbac Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Ceva
        6.9.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Ceva Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Vetoquinol
        6.10.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Vetoquinol Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 CAHIC
    6.12 Ringpu
    6.13 Dahuanong
    6.14 TECON
    6.15 BIOK
    6.16 Lukang Pharma
    6.17 JINYU Group
    6.18 China Animal Healthcare
    6.19 Jiangxi Yiling
    6.20 JIZHONG Pharmaceutical

7 Veterinary Pharmaceuticals Manufacturing Cost Analysis
    7.1 Veterinary Pharmaceuticals Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Veterinary Pharmaceuticals

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Veterinary Pharmaceuticals Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Veterinary Pharmaceuticals Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Veterinary Pharmaceuticals Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Veterinary Pharmaceuticals Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Veterinary Pharmaceuticals Sales Volume Forecast by Type (2017-2022)
    11.3 United States Veterinary Pharmaceuticals Sales Volume Forecast by Application (2017-2022)
    11.4 United States Veterinary Pharmaceuticals Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer